Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹273 Cr₹205 Cr₹84 Cr₹57 Cr₹24 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹273 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹273 Cr
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr
Mar2021₹24 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹273 Cr
33.00
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr
140.72
Mar2021 ₹24 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹12,093.6 Cr -1.5% 2.1% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,382.0 Cr 0.8% 7.3% 15.6% Stock Analytics
DIVIS LABORATORIES ₹194,375.0 Cr 1.9% 8.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,308.0 Cr 0.6% 12.6% 43.9% Stock Analytics
CIPLA ₹116,447.0 Cr 0.2% 6.3% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,106.0 Cr -1.8% -3.5% -3.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1.5%

2.1%

4.9%

SENSEX

0.1%

0.7%

-6.6%


You may also like the below Video Courses